
Michael P. Barker
Examiner (ID: 12574, Phone: (571)272-0303 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, OPQA, 1655 |
| Total Applications | 1330 |
| Issued Applications | 1017 |
| Pending Applications | 61 |
| Abandoned Applications | 256 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14715451
[patent_doc_number] => 20190248789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/392889
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/392889 | P2X | Apr 23, 2019 | Issued |
Array
(
[id] => 17821511
[patent_doc_number] => 11426434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
[patent_app_type] => utility
[patent_app_number] => 16/383612
[patent_app_country] => US
[patent_app_date] => 2019-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 9621
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383612
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383612 | Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby | Apr 13, 2019 | Issued |
Array
(
[id] => 14649239
[patent_doc_number] => 20190231748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => COMPOSITION FOR VAGINA AND ANTIMICROBIAL AGENT COMBINATION FOR USE IN PREPARING COMPOSITION FOR VAGINA
[patent_app_type] => utility
[patent_app_number] => 16/379779
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379779 | COMPOSITION FOR VAGINA AND ANTIMICROBIAL AGENT COMBINATION FOR USE IN PREPARING COMPOSITION FOR VAGINA | Apr 8, 2019 | Abandoned |
Array
(
[id] => 16320129
[patent_doc_number] => 10780076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Inhibition of cancer cell motility
[patent_app_type] => utility
[patent_app_number] => 16/358233
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 76
[patent_no_of_words] => 21119
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358233 | Inhibition of cancer cell motility | Mar 18, 2019 | Issued |
Array
(
[id] => 16555757
[patent_doc_number] => 20210000905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Crude Drug Composition For Preventing Or Treating Respiratory Diseases
[patent_app_type] => utility
[patent_app_number] => 16/980917
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980917 | Crude drug composition for preventing or treating respiratory diseases | Mar 14, 2019 | Issued |
Array
(
[id] => 15102151
[patent_doc_number] => 10472375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
[patent_app_type] => utility
[patent_app_number] => 16/298460
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 13552
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298460 | 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative | Mar 10, 2019 | Issued |
| 16/295208 | Limonoid Compounds for Treatment of Cancer | Mar 6, 2019 | Abandoned |
Array
(
[id] => 15468473
[patent_doc_number] => 10550099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/290328
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 55234
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290328 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Feb 28, 2019 | Issued |
Array
(
[id] => 14497721
[patent_doc_number] => 20190192515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => 1-PYRAZOLYL-3-(4-((2-ANILINOPYRIMIDIN-4 -YL) OXY) NAPTHTHALEN-1 - YL) UREAS AS P38 MAP KNASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/285560
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285560
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285560 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors | Feb 25, 2019 | Issued |
Array
(
[id] => 14743631
[patent_doc_number] => 20190254989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITION FOR PREVENTING OR REDUCING NEPHROTOXICITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/282203
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282203 | Composition for preventing or reducing nephrotoxicity and use thereof | Feb 20, 2019 | Issued |
Array
(
[id] => 16197444
[patent_doc_number] => 10722581
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-07-28
[patent_title] => Phonophoretic cannabidiol composition and transdermal delivery system
[patent_app_type] => utility
[patent_app_number] => 16/280561
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4191
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280561 | Phonophoretic cannabidiol composition and transdermal delivery system | Feb 19, 2019 | Issued |
Array
(
[id] => 15070961
[patent_doc_number] => 10464956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
[patent_app_type] => utility
[patent_app_number] => 16/276139
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30326
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 827
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/276139 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | Feb 13, 2019 | Issued |
Array
(
[id] => 14375065
[patent_doc_number] => 20190161445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => Urea Derivative Or Pharmacologically Acceptable Salt Thereof
[patent_app_type] => utility
[patent_app_number] => 16/270363
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270363 | Urea derivative or pharmacologically acceptable salt thereof | Feb 6, 2019 | Issued |
Array
(
[id] => 14684845
[patent_doc_number] => 20190241537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Odorless Cannabis Products and Processes for Their Preparation
[patent_app_type] => utility
[patent_app_number] => 16/267383
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/267383 | Odorless Cannabis Products and Processes for Their Preparation | Feb 3, 2019 | Abandoned |
Array
(
[id] => 16204857
[patent_doc_number] => 20200237847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Herbal composition for metabolic syndromes and method of treatment thereof
[patent_app_type] => utility
[patent_app_number] => 16/258599
[patent_app_country] => US
[patent_app_date] => 2019-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/258599 | Herbal composition for metabolic syndromes and method of treatment thereof | Jan 26, 2019 | Abandoned |
Array
(
[id] => 14338833
[patent_doc_number] => 20190151389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => DETOXIFYING COMPOSITION CONTAINING NEW GREEN EXTRACT AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/254712
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254712 | Detoxifying composition containing new green extract as active ingredient | Jan 22, 2019 | Issued |
Array
(
[id] => 18700027
[patent_doc_number] => 11786513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Compositions comprising berberine
[patent_app_type] => utility
[patent_app_number] => 16/966298
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4560
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966298
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966298 | Compositions comprising berberine | Jan 21, 2019 | Issued |
Array
(
[id] => 18635152
[patent_doc_number] => 11759724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources
[patent_app_type] => utility
[patent_app_number] => 16/244714
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5933
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244714 | Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources | Jan 9, 2019 | Issued |
Array
(
[id] => 15723063
[patent_doc_number] => 10609944
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-04-07
[patent_title] => Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
[patent_app_type] => utility
[patent_app_number] => 16/239463
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3235
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16239463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/239463 | Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol | Jan 2, 2019 | Issued |
Array
(
[id] => 14566777
[patent_doc_number] => 20190210995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/235524
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235524 | QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS | Dec 27, 2018 | Abandoned |